Shanghai Haoyuan Chemexpress Co.Ltd(688131) announced that the company plans to acquire 100% equity of YaoYuan Pharmaceutical Chemistry (Shanghai) Co., Ltd. (hereinafter referred to as “YaoYuan”) from Wang Yuan (Wang Yuan), Shanghai Yuanmeng enterprise management consulting partnership (limited partnership), Qidong Yuanli enterprise management consulting partnership (limited partnership) and Ningbo Jiusheng innovative pharmaceutical technology Co., Ltd, At the same time, it is proposed to issue shares to the controlling shareholder of the company, Shanghai Anshu Information Technology Co., Ltd., to raise supporting funds of no more than 50 million yuan. The trading of the company’s shares has been suspended since the opening of the market on February 21, 2022, and the suspension is expected to be no more than 10 trading days.
© China Stock Market News